Clinical Trial

Pacemaker-related Tricuspid Regurgitation Progression and Long-term Outcomes

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 30, 2025 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
Tricuspid regurgitation (TR) is a common complication following cardiac implantable electronic device (CIED) implantation, with severe TR being associated with increased rates of heart failure hospitalization and all-cause mortality, significantly impairing patients' quality of life. With technological advancements, physiological pacing modalities have demonstrated superior clinical efficacy and safety profiles compared to conventional pacing methods. This study aims to evaluate predictors of adverse outcomes and TR progression in CIED recipients under different pacing modalities, thereby providing clinical guidance for high-risk patients.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-04-03.
Status change: Not Yet Recruiting → Recruiting 2025-04-26
Trial Details
NCT Number NCT06922526
Lead Sponsor Haiyan Wang
Conditions Tricuspid Regurgitation, Pacemaker
Enrollment 200 participants
Start Date 2025-04
Primary Completion 2026-03 (estimated)
Study Completion 2026-05 (estimated)
Updated on ClinicalTrials.gov 2025-04-30